Gregory M Richards

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. ncbi request reprint Linear accelerator radiosurgery for trigeminal neuralgia
    Gregory M Richards
    Department of Human Oncology, University of Wisconsin Medical School, K4 B29 Clinical Sciences Center, Madison, Wisconsin 53792, USA
    Neurosurgery 57:1193-200; discussion 1193-200. 2005
  2. pmc Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience
    Anne M Traynor
    Section of Hematology and Medical Oncology, University of Wisconsin, Paul P Carbone Comprehensive Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Head Neck 32:599-606. 2010
  3. doi request reprint Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapy
    Jarrod B Adkison
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Int J Radiat Oncol Biol Phys 79:835-41. 2011
  4. ncbi request reprint Motexafin gadolinium: a novel radiosensitizer for brain tumors
    Afshin Forouzannia
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Clinical Science Center, Madison, WI 53792, USA
    Expert Rev Anticancer Ther 7:785-94. 2007
  5. doi request reprint Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region
    Gregory M Richards
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Breast Cancer Res Treat 114:307-13. 2009
  6. ncbi request reprint Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison
    C Wesley Hodge
    Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison, WI 53792, USA
    Int J Radiat Oncol Biol Phys 69:1032-41. 2007
  7. ncbi request reprint Motexafin gadolinium in the treatment of brain metastases
    Gregory M Richards
    University of Wisconsin School of Medicine and Public Health, Department of Human Oncology, Madison, WI 53792, USA
    Expert Opin Pharmacother 8:351-9. 2007
  8. ncbi request reprint Planned postradiotherapy neck dissection: Rationale and clinical outcomes
    Gregory K Sewall
    Division of Otolaryngology Head and Neck Surgery, Department of Surgery, University of Wisconsin Hospital and Clinics, Madison, Wisconsin 53792, USA
    Laryngoscope 117:121-8. 2007
  9. ncbi request reprint Therapeutic management of metastatic brain tumors
    Gregory M Richards
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Crit Rev Oncol Hematol 61:70-8. 2007
  10. ncbi request reprint Comparison of linac based fractionated stereotactic radiotherapy and tomotherapy treatment plans for skull-base tumors
    Emilie T Soisson
    Department of Medical Physics, University of Wisconsin Medical School, Madison, WI 53792, USA
    Radiother Oncol 78:313-21. 2006

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Linear accelerator radiosurgery for trigeminal neuralgia
    Gregory M Richards
    Department of Human Oncology, University of Wisconsin Medical School, K4 B29 Clinical Sciences Center, Madison, Wisconsin 53792, USA
    Neurosurgery 57:1193-200; discussion 1193-200. 2005
    ..To report the clinical outcomes following treatment of trigeminal neuralgia with linear accelerator-based radiosurgery...
  2. pmc Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience
    Anne M Traynor
    Section of Hematology and Medical Oncology, University of Wisconsin, Paul P Carbone Comprehensive Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Head Neck 32:599-606. 2010
    ....
  3. doi request reprint Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapy
    Jarrod B Adkison
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Int J Radiat Oncol Biol Phys 79:835-41. 2011
    ..Pulsed reduced-dose-rate radiotherapy (PRDR) is a reirradiation technique that reduces the effective dose rate and increases the treatment time, allowing sublethal damage repair during irradiation...
  4. ncbi request reprint Motexafin gadolinium: a novel radiosensitizer for brain tumors
    Afshin Forouzannia
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Clinical Science Center, Madison, WI 53792, USA
    Expert Rev Anticancer Ther 7:785-94. 2007
    ..Motexafin gadolinium is very well tolerated with tumor specific uptake. The rationale for the use of this drug as well as its current and future role as a radiation enhancer in the management of brain tumors is reviewed...
  5. doi request reprint Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region
    Gregory M Richards
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Breast Cancer Res Treat 114:307-13. 2009
    ..2 Gy pulses separated by 3-min time intervals is delivered, creating an apparent dose rate of 0.0667 Gy/min. Here we describe our early experience with PRDR...
  6. ncbi request reprint Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison
    C Wesley Hodge
    Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison, WI 53792, USA
    Int J Radiat Oncol Biol Phys 69:1032-41. 2007
    ....
  7. ncbi request reprint Motexafin gadolinium in the treatment of brain metastases
    Gregory M Richards
    University of Wisconsin School of Medicine and Public Health, Department of Human Oncology, Madison, WI 53792, USA
    Expert Opin Pharmacother 8:351-9. 2007
    ....
  8. ncbi request reprint Planned postradiotherapy neck dissection: Rationale and clinical outcomes
    Gregory K Sewall
    Division of Otolaryngology Head and Neck Surgery, Department of Surgery, University of Wisconsin Hospital and Clinics, Madison, Wisconsin 53792, USA
    Laryngoscope 117:121-8. 2007
    ....
  9. ncbi request reprint Therapeutic management of metastatic brain tumors
    Gregory M Richards
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Crit Rev Oncol Hematol 61:70-8. 2007
    ..Efforts to incorporate these approaches to improve survival are currently under active investigation...
  10. ncbi request reprint Comparison of linac based fractionated stereotactic radiotherapy and tomotherapy treatment plans for skull-base tumors
    Emilie T Soisson
    Department of Medical Physics, University of Wisconsin Medical School, Madison, WI 53792, USA
    Radiother Oncol 78:313-21. 2006
    ..To compare and evaluate helical tomotherapy and linac based fractionated stereotactic radiotherapy (FSRT) techniques in the treatment of skull-base tumors...
  11. ncbi request reprint Customized conformal high-dose-rate brachytherapy boost for limited-volume nasopharyngeal cancer
    Tracy Ng
    Department of Radiation Oncology, St Vincent s Comprehensive Cancer Center, 325 West 15th Street, New York, NY 10011, USA
    Int J Radiat Oncol Biol Phys 61:754-61. 2005
    ..To determine the feasibility of and patient outcomes using customized high-dose-rate (HDR) brachytherapy to boost the nasopharynx after external beam radiation therapy (EBRT) in patients with carcinoma of the nasopharynx...
  12. ncbi request reprint Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer
    Gregory M Richards
    Department of Radiation Oncology, St Vincent s Comprehensive Cancer Center, 325 W 15th Street, New York, NY 10011, USA
    Ann Surg Oncol 11:739-46. 2004
    ....